A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma

Clinical trial NCT02608125 · TERMINATED

Trial details

NCT number: NCT02608125
Sponsor: Principia Biopharma, a Sanofi Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter

Start date: 2015-10-28
Primary completion: 2020-06-23
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.